Convenient, timely access to clinical trial protocols has long been a problem in the pharmaceutical industry as these critical study documents are still largely distributed as paper documents. It’s not...
Foreseeing a global pandemic is not in any business leader’s job description. But perhaps the most vital skill for today’s…
GlaxoSmithKline (GSK) has reported positive results from Phase I/II clinical trials of Respiratory Syncytial Virus (RSV) vaccine candidates for maternal immunisation and older adults. Data…
Merck (MSD) has reported positive results from the Phase III PNEU-PATH and PNEU-DAY trials of its investigational 15-valent pneumococcal conjugate vaccine, V114, against pneumococcal disease.…
Pfizer and BioNTech have begun combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against Covid-19…
Biopharma firm Aptinyx has reported positive results from the first Phase II study of its new NMDA receptor modulator, NYX-783,…
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of its cannabis-derived medical products and…
Biopharmaceutical company VelosBio has dosed the first patient in a Phase II trial of investigational drug VLS-101 in patients with…
On the 9th of October, Alkermes announced positive voting from the joint meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee…
With the persisting global devastation of COVID-19, researchers worldwide are moving at a rapid pace to identify and develop viable vaccine candidates. Second waves of COVID-19 worldwide will coincide with…
by Reynald Castaneda in London. AstraZeneca’s Covid-19 vaccine AZD1222 splits experts as to whether its trials restarted too quickly on the heels of a second volunteer having a neurological event.…
Trials disrupted due to Covid-19 continue to resume
Since early March, more than 500 companies have publicly announced clinical trial disruptions, both planned and ongoing, due to the Covid-19 pandemic. Many companies have delayed the initiation of planned…